Background:There is relatively little methylation array data available specifically for oral
squamous cell carcinoma (OSCC). This study aims to compare the DNA methylome across a
large cohort of tumour/normal pairs.Methods:DNA was extracted from 44 OSCCs and paired normal mucosa. DNA methylation analysis
employed the Illumina GoldenGate high-throughput array comprising 1505 CpG loci selected
from 807 epigenetically regulated genes. This data was correlated with extracapsular
spread (ECS), human papilloma virus (HPV) status, recurrence and 5-year survival.Results:Differential methylation levels of a number of genes distinguished the tumour tissue
sample from the matched normal. Putative methylation signatures for ECS and recurrence
were identified. The concept of concordant methylation or CpG island methylator
phenotype (CIMP) in OSCC is supported by our data, with an association between
‘CIMP-high' and worse prognosis. Epigenetic deregulation of NOTCH4
signalling in OSCC was also observed, as part of a possible methylation signature for
recurrence, with parallels to recently discovered NOTCH mutations in HNSCC.
Differences in methylation in HPV-driven cases were seen, but are less significant than
that has been recently proposed in other series.Conclusion:Although OSCC seems as much an ‘epigenetic' as a genetic disease, the
translational potential of cancer epigenetics has yet to be fully exploited. This data
points to the application of epigenetic biomarkers and targets available to further the
development of therapy in OSCC.
Background. Treatment of recurrent oropharyngeal cancer is widely thought to have poor outcomes. Justification for treatment, especially in advanced cases, can be difficult. Methods. A systematic search of MEDLINE, Embase, and Cochrane databases was conducted. Included studies reported specific recurrent oropharyngeal cancer survival data.Results. Twenty-two retrospective studies were included. Pooled 3-year overall survival (OS) was 26% (95% confidence interval [CI] 5 22% to 29%; I squared 5 40.7%; p 5 .057). Pooled 5-year OS was 23% (95% CI 5 20% to 27%; I squared 5 73.9%; p 5 .000). Surgical treatment was superior to radiation (5-year OS 26% vs 16%, respectively; p <
Background:Extracapsular spread (ECS) in cervical lymph nodes is the single-most prognostic clinical variable in oral squamous cell carcinoma (OSCC), but diagnosis is possible only after histopathological examination. A promising biomarker in the primary tumour, alpha smooth muscle actin (SMA) has been shown to be highly prognostic, however, validated biomarkers to predict ECS prior to primary treatment are not yet available.Methods:In 102 OSCC cases, conventional imaging was compared with pTNM staging. SERPINE1, identified from expression microarray of primary tumours as a potential biomarker for ECS, was validated through mRNA expression, and by immunohistochemistry (IHC) on a tissue microarray from the same cohort. Similarly, expression of SMA was also compared with its association with ECS and survival. Expression was analysed separately in the tumour centre and advancing front; and prognostic capability determined using Kaplan–Meier survival analysis.Results:Immunohistochemistry indicated that both SERPINE1 and SMA expression at the tumour-advancing front were significantly associated with ECS (P<0.001). ECS was associated with expression of either or both proteins in all cases. SMA+/SERPINE1+ expression in combination was highly significantly associated with poor survival (P<0.001). MRI showed poor sensitivity for detection of nodal metastasis (56%) and ECS (7%). Both separately, and in combination, SERPINE1 and SMA were superior to MRI for the detection of ECS (sensitivity: SERPINE1: 95% SMA: 82% combination: 81%).Conclusion:A combination of SMA and SERPINE1 IHC offer potential as prognostic biomarkers in OSCC. Our findings suggest that biomarkers at the invasive front are likely to be necessary in prediction of ECS or in therapeutic stratification.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.